Literature DB >> 16081818

Recombinant CD200 protein does not bind activating proteins closely related to CD200 receptor.

Deborah Hatherley1, Holly M Cherwinski, Mehrdad Moshref, A Neil Barclay.   

Abstract

CD200 (OX2) is a cell surface glycoprotein that interacts with a structurally related receptor (CD200R) expressed mainly on myeloid cells and is involved in regulation of macrophage and mast cell function. In mouse there are up to five genes related to CD200R with conflicting data as to whether they bind CD200. We show that mouse CD200 binds the inhibitory receptor CD200R with a comparable affinity (Kd = 4 microM) to those found for the rat and human CD200 CD200R interactions. CD200 gave negligible binding to the activating receptors, CD200RLa, CD200RLb, and CD200RLc, by direct analysis at the protein level using recombinant monomeric and dimeric fusion proteins or to CD200RLa and CD200RLb when expressed at the cell surface. An additional potential activating gene, CD200RLe, found in only some mouse strains also did not bind CD200. Thus, the CD200 receptor family consists of both activatory and inhibitory members like several other paired ligand receptors, such as signal regulatory protein, killer cell Ig-like receptor/KAR, LY49, dendritic cell immunoreceptor/dendritic cell immunoactivating receptor, and paired Ig-like type 2 receptor. Although the ligand for the inhibitory product is a widely distributed host protein, the ligands of the activating forms remain to be identified, and one possibility is that they are pathogen components.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16081818     DOI: 10.4049/jimmunol.175.4.2469

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  Herpesvirus orthologues of CD200 bind host CD200R but not related activating receptors.

Authors:  Lai Shan Kwong; Munir Akkaya; A Neil Barclay; Deborah Hatherley
Journal:  J Gen Virol       Date:  2015-11-04       Impact factor: 3.891

2.  Identification of leucocyte surface protein interactions by high-throughput screening with multivalent reagents.

Authors:  Lei Jiang; A Neil Barclay
Journal:  Immunology       Date:  2010-01       Impact factor: 7.397

3.  Immunomodulator CD200 Promotes Neurotrophic Activity by Interacting with and Activating the Fibroblast Growth Factor Receptor.

Authors:  Stanislava Pankratova; Halla Bjornsdottir; Claus Christensen; Lanjun Zhang; Shizhong Li; Oksana Dmytriyeva; Elisabeth Bock; Vladimir Berezin
Journal:  Mol Neurobiol       Date:  2014-12-11       Impact factor: 5.590

4.  CD200R1 agonist attenuates mechanisms of chronic disease in a murine model of multiple sclerosis.

Authors:  Yingru Liu; Yoshio Bando; David Vargas-Lowy; Wassim Elyaman; Samia J Khoury; Tao Huang; Karin Reif; Tanuja Chitnis
Journal:  J Neurosci       Date:  2010-02-10       Impact factor: 6.167

5.  CD200R1 regulates the severity of arthritis but has minimal impact on the adaptive immune response.

Authors:  E Simelyte; S Alzabin; I Boudakov; R Williams
Journal:  Clin Exp Immunol       Date:  2010-10       Impact factor: 4.330

Review 6.  Is the CD200/CD200 receptor interaction more than just a myeloid cell inhibitory signal?

Authors:  Konstantinos Minas; Janet Liversidge
Journal:  Crit Rev Immunol       Date:  2006       Impact factor: 2.214

7.  Heterogeneity in the CD200R paired receptor family.

Authors:  Munir Akkaya; A Neil Barclay
Journal:  Immunogenetics       Date:  2009-12-05       Impact factor: 2.846

Review 8.  Signal initiation in biological systems: the properties and detection of transient extracellular protein interactions.

Authors:  Gavin J Wright
Journal:  Mol Biosyst       Date:  2009-12

9.  New assay to detect low-affinity interactions and characterization of leukocyte receptors for collagen including leukocyte-associated Ig-like receptor-1 (LAIR-1).

Authors:  Lei Jiang; A Neil Barclay
Journal:  Eur J Immunol       Date:  2009-04       Impact factor: 5.532

10.  CD200 and its receptor, CD200R, modulate bone mass via the differentiation of osteoclasts.

Authors:  Weiguo Cui; Esteban Cuartas; Juan Ke; Qing Zhang; Halldor B Einarsson; Jonathon D Sedgwick; Jun Li; Agnès Vignery
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.